Given the biological role of IL-2/IL-2R in ALCL, the recent development of IL-2Rα-targeting strategies39,40, and the medical need for new treatment approaches for subgroups of ALCL, we explored IL-2Rα as therapeutic target in ALCL. The gene discussed is IL2RA; the disease is anaplastic large cell lymphoma.